BRIEF-Acrux Says Us FDA Accepted For Review Co's Abbreviated New Drug Application
BRIEF-Acrux Says Us FDA Accepted For Review Co's Abbreviated New Drug Application
Brief-Acrux表示，美國FDA接受了審查公司的簡化新葯申請
((Reuters.Briefs@thomsonreuters.com;))Sept 13 (Reuters) - Acrux Ltd ACR.AX :
路透9月13日電-Acrux Ltd ACR.AX：
* US FOOD AND DRUG ADMINISTRATION HAS ACCEPTED FOR REVIEW CO'S ABBREVIATED NEW DRUG APPLICATION FOR ITS GENERIC VERSION OF DAPSONE GEL, 5%
*美國食品和藥物管理局(FDA)已接受CO對其仿製版本氨苯碸凝膠的簡短新葯申請進行審查，5%
Source text for Eikon: ID:nASXvtvrV Further company coverage: ACR.AX
Eikon的源文本：ID：nASXvtwrV進一步的公司報道：ACR.AX
((Reuters.Briefs@thomsonreuters.com;))
(Reurs.Briefs@thomsonreurs.com；)
資訊熱榜
更新時間